Physician profile
John Mignone
NPI 1194834127
$18,581.19
in general payments reported to CMS, 2019-2025
18 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,204 · 2020: $545 · 2021: $1,275 · 2022: $660 · 2023: $8,218 · 2024: $3,520 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $1,127 · Travel and Lodging: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,650.00 |
| Food and Beverage | $1,127.31 |
| Travel and Lodging | $120.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $7,653.63 | 2023 | Jardiance |
| Medtronic Vascular, INC. | $3,864.74 | 2019 | |
| Medtronic, INC. | $3,215.17 | 2021-2024 | Cobalt Dr Mri Surescan |
| Abbott Laboratories | $1,475.36 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, 2nd Gen Centrimag Primary Console |
| Lilly USA, LLC | $1,050.00 | 2024 | Jardiance |
| Impulse Dynamics (USA) INC. | $294.33 | 2022-2023 | Optimizer |
| Abiomed | $289.49 | 2023-2025 | Impella |
| Cvrx, INC. | $261.69 | 2020-2023 | Barostim Neo System |
| Janssen Scientific Affairs, LLC | $153.34 | 2022 | |
| Boston Scientific Corporation | $98.58 | 2019 | |
| Edwards Lifesciences Corporation | $62.63 | 2021 | |
| Catheter Precision INC. | $49.83 | 2023 | |
| Atricure, INC. | $47.80 | 2023 | |
| Novartis Pharmaceuticals Corporation | $24.38 | 2019 | |
| Abbvie INC. | $22.66 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sensible Medical Innovations INC | $17.56 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mignone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.